Skip to the page

Data / Medical devices / Canada / Response Biomedical Corp.

Response Biomedical Corp.: FDA-registered device maker in Vancouver British Columbia, Canada, 6 510(k) clearances

Response Biomedical Corp. is registered with the FDA (registration 3004205692) in Vancouver British Columbia, Canada. It lists 7 device types. The FDA files 6 510(k) clearances under its listings, the newest dated July 24, 2009. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3004205692
Address
1781-75th Avenue W., Vancouver British Columbia, Canada, V6P 6P2
Owner or operator
Response Biomedical Corp. (9046777)
Roles
Manufacturer, Repackager or relabeler
First device listed
July 15, 2004
Registered through
2026
Brand names listed
RAMP Cardiac Controls, RAMP® 200, RAMP® CK-MB, RAMP® Myoglobin, RAMP® NT-proBNP, RAMP® RSV, RAMP® RSV Control Swabs, RAMP® Reader and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
July 24, 2009K091235RAMP RSV ASSAYGQGSubstantially EquivalentResponse Biomedical Corp.accessdata.fda.gov
July 21, 2008K063662RAMP NT-PROBNP ASSAYNBCSubstantially EquivalentResponse Biomedical Corp.accessdata.fda.gov
June 2, 2008K080973CLINIQA LIQUID QC COMPLETE CARDIAC MARKER CONTROL, LEVELS 1,2, AND 3; CARDIAC MARKER CONTROL-LOW, AND LINICAL CARDIACJJYSubstantially EquivalentCliniqa Corporationaccessdata.fda.gov
May 17, 2004K033747RAMP CK-MB ASSAYJHXSubstantially EquivalentResponse Biomedical Corp.accessdata.fda.gov
May 17, 2004K033745RAMP TROPONIN I ASSAYMMISubstantially EquivalentResponse Biomedical Corp.accessdata.fda.gov
December 18, 2001K012040RAMP MYOGLOBIN ASSAYDDRSubstantially EquivalentResponse Biomedical Corp.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
March 15, 201984514Class IITerminatedRandox Laboratories Ltd. Catalogue Number CQ5052, Lot Number 4244CK (relabeled as Response Biomedical Catalogue Number C2003-2, Lot #070318) IFU: "RAMP Cardiac Controls *** CAT. No.: C2003-2 *** Size: 3 x 3 ML". Product The form received three complaints related to the user obtaining a result that fell below the target range for CK-MB provided in the RAMP Cardiac Controls Instructions for Use. Via in-house monitoring, determined that liquid Cardiac Control has seen a decrease in CK-MB Levels of up to 57% signal loss within 11 months. Shelf-life of product is 24 months.accessdata.fda.gov

Compare with other makers

Updated July 24, 2009. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.